Region Generally Lacks Patent Term Restoration

To read the full article, please choose one of the following options:

BMI View: The lack of patent term restoration (PTR) in most key Latin American countries restricts research-based pharmaceutical companies from maximising profits in the high-growth region. Chile and Costa Rica permit PTR, suggesting a favourable regulatory environment in these countries; however, their relatively small market sizes limit expansion potential for multinational drugmakers.